Free Trial

Enanta Pharmaceuticals (ENTA) SEC Filings & 10K Form

Enanta Pharmaceuticals logo
$9.34 +0.03 (+0.32%)
(As of 11/22/2024 ET)

Recent Enanta Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/14/2024
3:03 PM
ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
10/17/2024
3:31 PM
Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
08/09/2024
4:24 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
3:00 PM
Enanta Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
4:29 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
4:30 PM
Enanta Pharmaceuticals (Subject)
Rottinghaus Scott T. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
7:38 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:23 PM
Enanta Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:27 PM
Enanta Pharmaceuticals (Issuer)
Russell Lesley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:30 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:15 PM
Enanta Pharmaceuticals (Issuer)
FOLETTA MARK G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:19 PM
Enanta Pharmaceuticals (Issuer)
Hata Yujiro S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:12 PM
CARTER BRUCE L A (Reporting)
Enanta Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
5:31 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
12:11 PM
Enanta Pharmaceuticals (Subject)
Krensavage Asset Management, LLC (Filed by)
Form SCHEDULE 13G
02/14/2024
7:21 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:23 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:00 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:09 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:12 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:15 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
7:18 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:26 PM
ARMISTICE CAPITAL, LLC (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
11:15 PM
Enanta Pharmaceuticals (Filer)
Form EFFECT
01/26/2024
8:11 AM
Enanta Pharmaceuticals (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SC 13G/A
01/24/2024
4:23 PM
BlackRock Inc. (Filed by)
Enanta Pharmaceuticals (Subject)
Form SC 13G/A
01/22/2024
11:25 AM
Enanta Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/11/2024
3:15 PM
Enanta Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
12/15/2023
7:08 PM
Enanta Pharmaceuticals (Issuer)
Vance Terry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
4:16 PM
Enanta Pharmaceuticals (Subject)
Vance Terry (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
7:26 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:29 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:31 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:17 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:19 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:22 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
7:24 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:24 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:08 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:11 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:15 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.
12/05/2023
8:19 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:21 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:10 PM
Enanta Pharmaceuticals (Issuer)
Luly Jay R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:10 PM
Enanta Pharmaceuticals (Issuer)
Rottinghaus Scott T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:11 PM
Enanta Pharmaceuticals (Issuer)
Or Yat Sun (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:11 PM
Enanta Pharmaceuticals (Issuer)
Gardiner Nathaniel S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:12 PM
Enanta Pharmaceuticals (Issuer)
MELLETT PAUL J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:12 PM
Enanta Pharmaceuticals (Issuer)
Kieffer Tara Lynn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:12 PM
Enanta Pharmaceuticals (Issuer)
Luu Brendan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:38 PM
Enanta Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/22/2023
3:12 PM
Enanta Pharmaceuticals (Filer)
Form POSASR
11/22/2023
3:21 PM
Enanta Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ENTA) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners